Stay updated on Optimal Tenecteplase Dose in Stroke Clinical Trial
Sign up to get notified when there's something new on the Optimal Tenecteplase Dose in Stroke Clinical Trial page.

Latest updates to the Optimal Tenecteplase Dose in Stroke Clinical Trial page
- Check3 days agoNo Change Detected
- Check10 days agoChange DetectedThe study page now displays a 403 Forbidden error instead of the previous study details. This indicates the page is currently inaccessible and no trial information is visible.SummaryDifference18%

- Check17 days agoNo Change Detected
- Check31 days agoChange DetectedRevision updated from v3.6.5 to v3.6.6, indicating a recent software update to the ClinicalTrials.gov interface.SummaryDifference0.0%

- Check52 days agoChange DetectedRevision updated from v3.6.4 to v3.6.5 on the page, signaling a new build of the site. The update likely includes internal fixes or improvements without modifying displayed study details.SummaryDifference0.0%

- Check67 days agoChange DetectedThe page’s revision was updated from v3.6.3 to v3.6.4, reflecting a new release of the page software.SummaryDifference0.0%

- Check88 days agoChange DetectedThe page footer revision has been updated from v3.6.2 to v3.6.3. This reflects a minor platform update and does not change the study details or functionality on the page.SummaryDifference0.0%

- Check95 days agoChange DetectedThe page now shows Revision: v3.6.2, replacing Revision: v3.6.0, indicating a newer build of the site's software. This appears to be an internal patch rather than a user-facing content change.SummaryDifference0.0%

Stay in the know with updates to Optimal Tenecteplase Dose in Stroke Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Optimal Tenecteplase Dose in Stroke Clinical Trial page.